OP0212 HIGHDOSE CHEMOTHERAPY AND TRANSPLANTATION OF 34+ SELECTED STEM CELLS FOR PROGRESSIVE SYSTEMIC...
OP0212 HIGHDOSE CHEMOTHERAPY AND TRANSPLANTATION OF 34+ SELECTED STEM CELLS FOR PROGRESSIVE SYSTEMIC SCLEROSIS WITH OR WITHOUT CARDIAC INVOLVEMENT OR ALVEOLITIS - MODIFICATION ACCORDING TO MANIFESTATION (AST MOMA)
About this item
Full title
Author / Creator
Pecher, A. C. , Kötter, I. , Klein, R. , Lengerke, C. , Peis, K. , Vogel, W. , Schmalzing, M. , Wirths, S. and Henes, J.
Publisher
Kidlington: BMJ Publishing Group Ltd and European League Against Rheumatism
Journal title
Language
English
Formats
Publication information
Publisher
Kidlington: BMJ Publishing Group Ltd and European League Against Rheumatism
Subjects
More information
Scope and Contents
Contents
Background:Autologous hematopoietic stem cell transplantation (aHSCT) for systemic sclerosis (SSc) has been proven the most effective treatment strategy with regard to overall and event free survival in selected patients [1]. Limitation is its toxicity.Objectives:To evaluate feasibility of aHSCT in patients with impaired lung or heart function. Sec...
Alternative Titles
Full title
OP0212 HIGHDOSE CHEMOTHERAPY AND TRANSPLANTATION OF 34+ SELECTED STEM CELLS FOR PROGRESSIVE SYSTEMIC SCLEROSIS WITH OR WITHOUT CARDIAC INVOLVEMENT OR ALVEOLITIS - MODIFICATION ACCORDING TO MANIFESTATION (AST MOMA)
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_3100828160
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3100828160
Other Identifiers
ISSN
0003-4967
E-ISSN
1468-2060
DOI
10.1136/annrheumdis-2024-eular.1742
